Optifarm SRL
2.4 FTEThe score of Optifarm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -5 % Total assets +128 % Headcount (avg FTE) +14 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Optifarm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jun 2026
- Year ended 31 Dec 2024filed on 27 May 2025
- Year ended 31 Dec 2023filed on 03 May 2024
- Year ended 31 Dec 2022filed on 30 May 2023
- Year ended 31 Dec 2021filed on 21 Jun 2022
Optifarm's financial analysis
- Solvency16.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Optifarm
Optifarm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0407.818.781
- VAT number
- BE0407818781
- Peppol
- Registered · 0208:0407818781 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Dec 1970
- Registered office
- 9620 Zottegem
- Size
- Micro · 2.4 FTE
- Latest accounts
- 2025 · filed on 15 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Optifarm (SRL) has been based in Zottegem since 1970, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 71,877 € and equity of 412,960 €; its revenue is not published. With 2.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 16.8%, below the median of its sector (44.2%).
Companies similar to Optifarm
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Tilman Retail sale of pharmaceutical products Durbuy · balance sheet €2.53m
- Apotheek Coene Retail sale of pharmaceutical products Zonnebeke · balance sheet €1.17m
- Huyghe-Hoebeke Retail sale of pharmaceutical products Lokeren · balance sheet €2.19m
- Optifar Retail sale of pharmaceutical products Dilbeek · balance sheet €1.54m
- Albanimmo Retail sale of pharmaceutical products Grez-Doiceau · balance sheet €2.53m
- Apotheken Peeters Retail sale of pharmaceutical products Lummen · balance sheet €1.44m
- Edis Invest Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet €2.26m
- Limafran Retail sale of pharmaceutical products Lincent · balance sheet €2.00m
Frequently asked questions about Optifarm
What is the revenue of Optifarm?
Optifarm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Optifarm?
In Belgium, the VAT number is the company number prefixed with BE: BE0407818781 for Optifarm, if the company is VAT-registered. Its company number (CBE) is 0407.818.781.
Where is the registered office of Optifarm?
According to the CBE register, the registered office of Optifarm is in 9620 Zottegem.
What is the equity of Optifarm?
At the close of the 2025 financial year, the equity of Optifarm amounts to 412,960 €, a solvency of 16.8% of total assets.
How many people work at Optifarm?
2.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Optifarm?
The register lists 2 active mandates at Optifarm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Optifarm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →